This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Rosetta Genomics Ltd.. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Esther Meiri: Innovator in Nucleic Acid Detection
Introduction
Esther Meiri is a prominent inventor based in Shoham, Israel. She has made significant contributions to the field of molecular biology, particularly in the detection of nucleic acids. Her innovative work has led to the development of methods that enhance the accuracy and efficiency of nucleic acid detection.
Latest Patents
Esther Meiri holds 1 patent for her invention titled "Method for detecting a target nucleic acid comprising two portions using probes having a first portion complementary to the first portion of the target nucleic acid and a second portion substantially complementary to the second portion of the target nucleic acid." This patent describes methods and compositions for detecting, amplifying, and labeling targeted nucleic acids, including microRNAs.
Career Highlights
Esther is associated with Rosetta Genomics Ltd., a company known for its advancements in genomic research and diagnostics. Her work at the company has been instrumental in pushing the boundaries of nucleic acid research.
Collaborations
Esther has collaborated with notable colleagues, including Shlomit Gilad and Gilad Shlomit, contributing to various projects that aim to improve nucleic acid detection techniques.
Conclusion
Esther Meiri's innovative contributions to nucleic acid detection have established her as a key figure in the field. Her work continues to influence advancements in molecular biology and diagnostics.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile